Patents by Inventor Stephane Hourcade

Stephane Hourcade has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted Cyclohexanecarboxamides, Their Preparation and Their Therapeutic Application
    Publication number: 20240124408
    Abstract: Compounds of formula (1): wherein R1 represents a —C(R2)(R3)—[C(R4)(R5)]m-L-R6 group or —R7; and the preparation and the therapeutic uses of the compounds of formula (1) as agonists of TRPM8 receptors, useful especially in the treatment of oropharyngeal dysphagia.
    Type: Application
    Filed: December 16, 2021
    Publication date: April 18, 2024
    Applicant: Sanofi
    Inventors: Paul Justin Mueller, Florian Auger, Guillaume Begis, Yann Foricher, Christoph Grebner, Stéphane Hourcade, Stéphanie Meyfroot, Sven Ruf, Klaus Wirth
  • Fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone HSP 90
    Patent number: 8163750
    Abstract: The present invention relates to compounds of formula (I): wherein R1, R2, R2?, L, Het, p and p? are as defined herein, compositions containing them, and their use as medicinal products.
    Type: Grant
    Filed: November 24, 2009
    Date of Patent: April 24, 2012
    Assignee: Sanofi-Aventis
    Inventors: Fabienne Thompson, Patrick Mailliet, Jean-Marie Ruxer, Helene Goulaouic, Francois Vallee, Herve Minoux, Fabienne Pilorge, Luc Bertin, Stephane Hourcade, Maria Mendez-Perez, Peter Hamley
  • 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
    Patent number: 7825112
    Abstract: The disclosure relates to 2-carbamide-4-phenylthiazole derivatives having the following general formula (I): wherein R1, R2, R3, Y and p are as defined in the disclosure. The disclosure also relates to pharmaceutical compositions containing a compound of formula (I), to processes for preparing the compounds of formula (I), and to methods of using the compounds of formula (I).
    Type: Grant
    Filed: June 26, 2008
    Date of Patent: November 2, 2010
    Assignee: sanofi-aventis
    Inventors: Pierre Casellas, Daniel Floutard, Pierre Fraisse, Stephane Hourcade, Samir Jegham
  • NEW FLUORENE DERIVATIVES, COMPOSITIONS CONTAINING THE SAME AND USE THEREOF AS INHIBITORS OF THE PROTEIN CHAPERONE HSP 90
    Publication number: 20100130503
    Abstract: The present invention relates to compounds of formula (I): wherein R1, R2, R2?, L, Het, p and p? are as defined herein, compositions containing them, and their use as medicinal products.
    Type: Application
    Filed: November 24, 2009
    Publication date: May 27, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Fabienne THOMPSON, Patrick MAILLIET, Jean-Marie RUXER, Helene GOULAOUIC, François VALLEE, Herve MINOUX, Fabienne PILORGE, Luc BERTIN, Stephane HOURCADE, Maria MENDEZ-PEREZ, Peter HAMLEY
  • 2-CARBAMIDE-4-PHENYLTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
    Publication number: 20090018117
    Abstract: The disclosure relates to 2-carbamide-4-phenylthiazole derivatives having the following general formula (I): wherein R1, R2, R3, Y and p are as defined in the disclosure. The disclosure also relates to pharmaceutical compositions containing a compound of formula (I), to processes for preparing the compounds of formula (I), and to methods of using the compounds of formula (I).
    Type: Application
    Filed: June 26, 2008
    Publication date: January 15, 2009
    Applicant: sanofi-aventis
    Inventors: Pierre CASELLAS, Daniel FLOUTARD, Pierre FRAISSE, Stephane HOURCADE, Samir JEGHAM